1 Strong Dividend Stock You Can Buy Right Now

Bank certificates of deposit and savings accounts pay almost nothing in interest right now. Fortunately, investors on the hunt for income don't need to gamble on the riskiest stocks out there.

Aug 29, 2014 at 3:33PM

Dividend investing is all the rage these days, and for good reason. With the S&P 500 Index sitting near an all-time high, dividends offer valuable downside protection. When the market goes down, dividends help provide a real return. And when the market goes up, dividends are simply icing on the cake.

Plus, with interest rates at historic lows, it's hard to find satisfactory yield. Bonds don't yield much, with the 10-Year U.S. Treasury at just 2.4%. Traditional savings vehicles like bank certificates of deposits and savings accounts are even worse, as many offer little or no interest.

This makes it difficult to find a decent yield without taking some risk. Fortunately, there are still stocks that fit the bill. One of them is healthcare behemoth Johnson & Johnson (NYSE:JNJ), which is a great dividend stock you can buy today.

Taking advantage of changing demographics
The United States is currently in a massive demographic shift. The country has an aging population, and this will result in high demand for health care going forward. To emphasize, consider that polling firm Gallup has calculated that Baby Boomers, or those born roughly between 1946-1964, are the largest generational group in the United States. By themselves, Baby Boomers represent about one-third of the total population.

J&J's huge and diverse businesses should capitalize on this demographic trend. In all, J&J holds more than 275 companies spread across more than 60 countries worldwide.

These companies are all contributing to the overall success J&J has experienced this year. Total sales are up 6.3% through the first half of the year. Organic sales are up an even better 7.4%, once you strip out the effects of foreign currency translation. Through the first six months, adjusted earnings per share increased 9.5%.

J&J's strong results are spread across its domestic and international markets. Organic sales are up 8.5% in the United States over the first half of the year, and 6.4% internationally over this period. The company is doing well in under-developed nations as well. For example, its international performance was led by Asia-Pacific and Africa, where sales rose 7.7% over the first six months.

What J&J can do for you
J&J is a 128-year old company that has an amazing track record of success. According to the company, it has increased adjusted profits for 30 years in a row, and has raised its dividend for 52 years in a row. Speaking of its dividend, J&J yields 2.7%, which beats the yield on the 10-Year U.S. Treasury and the overall stock market index.

Even better, J&J isn't aggressively valued. The company increased its full-year earnings forecast after providing second-quarter results. Management now expects to earn $5.89 in adjusted EPS this year, which would represent nearly 7% growth year over year.

Pharmaceuticals is helping drive that growth, led by autoimmune drug Remicade (which turned in 8% sales growth). In the consumer business, growth will be fueled by J&J's stable consumer business, which includes popular brands such as Tylenol and Listerine.

The Foolish takeaway
As stock markets climb and interest rates remain low, yield is hard to find. But you don't need to reach for the riskiest stocks to generate income from your investments. A great stock that offers a large and highly profitable business, in tandem with a strong dividend, is healthcare giant Johnson & Johnson.

J&J operates several large businesses that each contribute to growth. In turn, the company does a great job of sharing its success with investors. And, with the aging population in the United States, J&J has a bright future ahead.

Top dividend stocks for the next decade
The smartest investors know that dividend stocks -- like Johnson & Johnson -- simply crush their non-dividend paying counterparts over the long term. That’s beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor’s portfolio. To see our free report on these stocks, just click here now.

Bob Ciura has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers